Nutraceuticals such as hydroxytyrosol (Hidrox®) can be promising in ALS therapy since it modulates the Nrf2-regulated hemeoxygenase-1 (HO-1) pathway, NF-κB signalling, and sirtuin signalling [276]. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.